Discovery of the First Vitamin K Analogue as a Potential Treatment of Pharmacoresistant Seizures.
Discovery of the First Vitamin K Analogue as a Potential Treatment of Pharmacoresistant Seizures.
复制标题
DOI:
10.1021/acs.jmedchem.0c00168
复制
发表时间:
2020-06-11
影响因子:
7.3
通讯作者:
Chou CJ
中科院分区:
文献类型:
--
作者:
Li X;Himes RA;Prosser LC;Christie CF;Watt E;Edwards SF;Metcalf CS;West PJ;Wilcox KS;Chan SSL;Chou CJ
Despite the availability of more than 25 anti-seizure drugs on the market, approximately 30% of patients with epilepsy still suffer from seizures. Thus, the epilepsy therapy market has a great need for a breakthrough drug that will aid pharmacoresistant patients. In our previous study, we discovered a vitamin K analog, 2h, which displayed modest anti-seizure activity in zebrafish and mouse seizure models. However, there were limitations for this compound due to its pharmacokinetic profile. In this study, we developed a new series of vitamin K analogs by modifying the structure of 2h. Among these, compound 3d shows full protection in a rodent pharmacoresistant seizure model with limited rotarod motor toxicity and favorable PK properties. Furthermore, the brain/plasma concentration ratio of 3d indicates its excellent permeability to the brain. The resulting data shows 3d can be further developed as a potential anti-seizure drug in the clinic.
登录
查看更多内容
影响因子:
3.3
作者:
Rahn, J. J.;Bestman, J. E.;Josey, B. J.;Inks, E. S.;Stackley, K. D.;Rogers, C. E.;Chou, C. J.;Chan, S. S. L.
通讯作者:
Chan, S. S. L.
影响因子:
2.2
作者:
Barton, ME;Klein, BD;White, HS
通讯作者:
White, HS
影响因子:
5.6
作者:
Lyczkowski, DA;Pfeifer, HH;Thiele, EA
通讯作者:
Thiele, EA
影响因子:
4.4
作者:
Kehne, John H.;Klein, Brian D.;Sharma, Shalini
通讯作者:
Sharma, Shalini
影响因子:
5.6
作者:
Metcalf CS;West PJ;Thomson KE;Edwards SF;Smith MD;White HS;Wilcox KS
通讯作者:
Wilcox KS